baber/WOPTO huggingface dataset:
Patent EP-0513399-A4 (EP)
IPC: A63F3/02
Filed: 1991-11-25
Abstract: A game machine is provided with a board having a surface (11) configuring the game region where a metallic body as a medium moves, a cover (10a) covering the surface (11) and holding a space in which the metallic body moves on the surface (11), a mounting frame (38) for mounting the board and the cover. Also, the machine is provided with a matrix sensor (20) which is mounted on the cover (10a) and having sensor units for sensing the metallic body in the form of a matrix, and a signal processing unit for sensing the position of the metallic body on the surface (11) by driving the matrix sensor (20). At least part of the signal processing unit including the portion being in connection with the matrix sensor (20) is disposed on the outside of the game region in the space surrounded by the mounting frame (38). <IMAGE>
Patent EP-0538443-A4 (EP)
Title: Methods and formulations for use in inhibiting conception and in treating benign gynecological disorders
IPC: A61K9/16
Filed: 1992-04-10
Abstract: PCT No. PCT/US92/02973 Sec. 371 Date Feb. 1, 1993 Sec. 102(e) Date Feb. 1, 1993 PCT Filed Apr. 10, 1992.Compositions and methods which are effective to inhibit conception and to treat benign gynecological disorders for extended periods of time are described, wherein an effective amount of a gonadotropin hormone releasing hormone composition and an effective amount of an estrogenic composition are provided over a first period of time, in addition to a progestogen and optionally an androgenic composition. According to one protocol, the progestogen is provided for a second, shorter period of time; the progestogen is provided at a higher level for at least 5 to about 20 days, and then at a lower level for the remainder, if any, of the second period of time. In an alternative protocol, the progestogen is provided at a lower level substantially throughout the period of administration of gonadotropin hormone releasing hormone composition and estrogenic composition. An effective amount of the androgenic hormone is optionally provided over the first period of time.
Patent EP-0610286-A4 (EP)
Title: Recombinant immunotoxins.
Inventor: PASTAN IRA
IPC: C07K19/00
Filed: 1992-09-29
Abstract: The subject invention relates to recombinant immunotoxins, and to uses thereof. In particular, the invention relates to two immunotoxins, referred to as B3(Fv)-PE40 and B3(Fv)-PE38KDEL, which may be used in the treatment of mammalian cancer.
Patent EP-0649843-A4 (EP)
Title: Thiazoline derivative.
Inventor: SATO MASAKAZU TAISHO PHARMACEU
IPC: C07D277/56
Filed: 1993-07-08
Abstract: To provide a compound excellent in fibrinogen receptor antagonism and cell adhesion factor antagonism. A thiazoline derivative represented by general formula (I) and a salt thereof, wherein R<1> represents cyano, carbamoyl, thiocarbamoyl, morpholinothiocarbonyl, alkylthioimidoyl, -C(=NH)-NR<1><1>R<1><2> (wherein R<1><1> and R<1><2> represent each hydrogen, alkyl, alkoxycarbonyl, cycloalkyl, phenyl, substituted phenyl, aralkyl or substituted aralkyl, or alternatively R<1><1> and R<1><2> may be combined with each other to represent a monovalent heterocyclic group together with the adjacent nitrogen atom) or imidazolin-2-yl; R<2> represents alkyl or aralkyl; R<3> represents carboxy, hydroxy, alkoxycarbonyl, benzyloxycarbonyl or pyridyl-methyloxycarbonyl; and n represents an integer of 1 to 3. <CHEM>
Patent EP-0625159-A4 (EP)
Title: Ikaros: a t cell pathway regulatory gene.
Inventor: GEORGOPOULOS KATIA
IPC: C12N15/09
Filed: 1993-09-14
Abstract: Purified DNA including a sequence encoding an Ikaros protein.
Patent EP-0676399-A4 (EP)
Title: Methotrexate derivative.
Inventor: OHI NOBUHIRO
IPC: C07D475/08
Filed: 1993-12-24
Abstract: A compound represented by general formula (A), a salt thereof, and an antirheumatic containing at least one of them as the active ingredient, wherein R1 and R2 may be the same or different from each other and each represents hydrogen or C1-C4 alkyl. <CHEM>   <IMAGE>
Patent EP-0685020-A4 (EP)
Title: Method and system for remediation of groundwater contamination.
Inventor: VIGNERI RONALD J
IPC: B01F3/08
Filed: 1994-02-09
Abstract: A method for remediating a hydrocarbon-contaminated region of a subterranean body of groundwater to destroy or reduce the initial concentration levels of hydrocarbon contaminants. A plurality of mutually spaced wells are provided intersecting the groundwater region, and the existence of acceptable continuity and well interflow paths for the said region is determined by generating a test flow of a solution of hydrogen peroxide from one of the wells and monitoring pH changes at each other of the wells as a function of time to detect a pH drop of at least 0.2. Subsequent to detecting the pH drop, a treating flow of the hydrogen peroxide solution is provided from one or more of the wells. A system to enable the foregoing is also disclosed.
Patent EP-0686043-A4 (EP)
Title: Compositions and methods of application of reactive antiviral polymers
Inventor: WANG JUI H
IPC: C07H21/00
Filed: 1994-02-23
Abstract: Novel polyadenylic acid (5') derivatives with 2'-0-(3-fluoro-4,6-dinitrophenyl) groups and/or 2'-0-(2,4-dinitrophenyl) groups have been synthesized and discovered to act as mutation-insensitive and function-specific inhibitors of viral reverse transcriptase. The compositions, preparative procedures and methods of application of these novel compounds for the treatment of humans carrying or infected with AIDS virus and other RNA-viruses, of other mammals carrying RNA-viruses, for the fast but temporary protection of uninfected humans and other mammals against immuno-deficiency viruses and other RNA-virus caused diseases, for the preparation of a formulation containing irreversibly sterilized HIV or other RNA-viruses useful as anti-AIDS and anti-other RNA-virus disease vaccines, for the complete sterilization of possible trace amounts of live HIV and other RNA-viruses in stored transfusion blood, and for the inactivation or removal of trace amounts of ribonuclease in solution and containers used in biotechnology processes have all been disclosed.
Patent EP-0750706-A4 (EP)
Title: Concrete wall monolithic building unit
Inventor: PRUSS DONALD E
IPC: E04B2/86
Filed: 1995-03-14
Abstract: There is disclosed a monolithic unit having spaced apart panels (12, 14) for concrete walls in which the unit includes in one embodiment tie members (40) having a chemically similar polymeric composition to that of the panels (12, 14) but differing in a physical form. The result is a fusibly connected integral unit.
Patent EP-0754283-A4 (EP)
Title: Refrigeration system
Inventor: COVENTRY ANDREW
IPC: F25D3/10
Filed: 1995-04-21
Abstract: PCT No. PCT/AU95/00241 Sec. 371 Date Dec. 9, 1996 Sec. 102(e) Date Dec. 9, 1996 PCT Filed Apr. 21, 1995 PCT Pub. No. WO95/29372 PCT Pub. Date Nov. 2, 1995A refrigeration system (12) is comprised of three expansion units (19A, 19B, 19C), with each having an expansion chamber (22) and three secondary chambers (24, 26 and 28), connected to a supply (16) of compressed refrigerant. The expansion chamber and secondary chambers are formed with progressively reducing volumetric capacity. The end of each of the the secondary chambers, is connected to a common bleed tube (29) having a bleed hole (34) for venting the refrigerant. The bleed hole opens to the outside of a housing (15) which houses the expansion units. The interior of the housing (15) is filled with a gel which changes state from a liquid to a solid at a predetemmined temperature. A valving arrangement (32) connects the expansion units to a supply of compressed refrigerant. The housing (15) together with a supply (16) refrigerant can be installed into a cooling box for cooling the space within the cooling box. This is achieved by the valve mechanism (32) periodically admitting a volume of compressed refrigerant into the expansion units, wherein the compressed refrigerant initially expands in the expansion chambers. This in turn absorbs heat from the space within the box. The flow of expanded refrigerant through the secondary chambers is retarded by back pressure produced by having the secondary chambers of progressively reducing volumetric capacity. This allows the gel to be maintained at a frozen state for a long period of time while consuming only small volumes of compressed refrigerant.
Patent EP-0756581-A4 (EP)
Inventor: YOON ROE-HOAN
IPC: C02F11/147
Filed: 1995-04-17
Abstract: La présente invention permet de sécher avec efficacité un petit volume de substance particulaire humide par adjonction d'un agent d'hydrophobie destiné à recouvrir les surfaces des particules, puis par utilisation d'un fluide gazeux éliminant mécaniquement les gouttelettes d'eau des surfaces des particules. Lorsqu'il est sur la surface des particules, le réactif d'hydrophobie rend les particules relativement plus hydrophobes et augmente l'angle de contact entre les particules et l'eau, de préférence jusqu'à au moins 90°. Le réactif d'hydrophobie a pour fonction de chasser l'eau. Après avoir modifié les caractéristiques d'hydrophobie des particules, le fluide gazeux, qui est de préférence de l'air sous pression, est envoyé sous moyenne pression sur les surfaces des particules afin d'en éliminer l'eau. Etant donné la tendance de l'agent d'hydrophobie à augmenter la tendance des particules à chasser l'eau, l'eau se déplace facilement de la surface des particules dans des conditions douces. Le procédé convient à la déshydratation d'une grande variété de substances et notamment les particules de charbon, l'argile, les sulfures minéraux, les composés phosphoreux, les oxydes métalliques minéraux, les métaux et les boues des réseaux d'assainissement.
Patent EP-0721651-A4 (EP)
Title: A method and system for minimizing redundant topology updates using a black-out timer
Inventor: HUMBLET PIERRE A
IPC: H04Q3/00
Filed: 1995-06-05
Abstract: The method and system implement a black-out timer (606) to schedule intermediate network topology updates in coordination with a predetermined periodic network topology update timer (604) to minimize redundant topology updates. Topology update scheduling in accordance with present invention provides a significant enhancement to the efficiency to topology updating (602).
Patent EP-0778344-A4 (EP)
Title: Process for producing stabilized dry carboxyesterase
Inventor: UNO KAZUTAKA
IPC: C12N9/18
Filed: 1995-07-19
Abstract: The present invention relates to a process for producing a stable carboxylesterase in dry form. The dry enzyme composition is added to food and drink (e.g., bread, brewed seasonings, liquors, processed meat products) during the production process to thereby impart thereto a good aroma (ester aromas).
Patent EP-0754383-A4 (EP)
Inventor: CHEN WEI
IPC: H04L12/56
Filed: 1996-01-23
Abstract: Ce système de gestion (120) de largeur de bande gère une pluralité de connexions de données virtuelles dans un réseau de télécommunications, et il comprend une entrée (122) destinée à recevoir des cellules mémoire, chaque cellule étant associée à une connexion particulière parmi les connexions virtuelles. Ce système comprend également un regroupement de cellules couplé à l'entrée aux fins de stockage des cellules, des première et seconde files d'attente (126-128) servant à commander les connexions virtuelles, ainsi qu'une sortie (137) destinée à transmettre les cellules à partir du regroupement de cellules. La position relative de la connexion virtuelle dans la première file d'attente est déterminée par une éligibilité variable, laquelle varie en fonction d'une vitesse de transmission des données anticipée et associée à la connexion virtuelle particulière, ainsi qu'en fonction de la quantité de temps pendant lequel cette connexion est restée dans la première file d'attente. La position relative d'une connexion virtuelle dans la seconde file d'attente varie en fonction d'une qualité de service prédéterminée assignée à chacune des connexions virtuelles.
Patent EP-0852013-A4 (EP)
Title: Method for determining alcohol consumption rates
Inventor: HARASYMIW JAMES
IPC: G06F19/00
Filed: 1996-06-07
Abstract: A method for assessing or determining alcohol consumption rates including using a blood specimen from a human subject to develop an individual blood constituent panel; comparing the individual panel with a reference blood constituent panel to provide categories corresponding to rates of alcohol consumption; and identifying the category of consumption rate. The methods of the invention can be varied through modification of one of several statistical models used therewith to preferentially weigh the analysis and identify one consumption category over another. Multi-variate and similar such statistical techniques correlate comparisons of individual/subject blood and reference panel constituents with recognized consumptions rates.
Patent EP-0857018-A4 (EP)
Title: Betulinic acid derivatives and uses therefor
Inventor: LEE KUO-HSIUNG
IPC: A61K45/06
Filed: 1996-06-05
Abstract: Betulinic acid derivs. of formula (I) and (II) are new. In (I) the dotted line is a double bond; in (II) the dotted line is a single bond; R = opt. substd. 2-20C mono- or di-carboxyacyl; and R' = H, opt. substd. 2-20C alkyl, or aryl. Also claimed is a compsn. contg. (I) or (II), or their esters, salts, ethers, sulphates or glucuronides, and an anti-viral agent or an immunostimulating agent.
Patent EP-0916338-A4 (EP)
Inventor: SHIRAHASE HIROAKI
IPC: A61K31/35
Filed: 1997-06-06
Abstract: Agent anti-rhumatismal contenant du diéthyl-L-lysylcromoglycate de formule générale (I), ou sel non toxique de ce dernier. Ce composé possède une activité anti-inflammatoire et immunorégulatrice; pris par voie orale, il est bien amené jusqu'au site choisi; et il entraîne peu d'effets secondaires. Il peut donc être utile comme agent anti-rhumatismal destiné à une administration par voie orale.
Patent EP-0964465-A4 (EP)
IPC: H01M4/82
Filed: 1997-10-03
Abstract: Concave portions and convex portions are formed on a peripheral surface of a thin metal sheet by applying a pressing force thereto while the metal sheet is being embossed; pores are each formed on an apex of each of the concave portions and convex portions and burrs each projecting outward from a peripheral edge of each of the pores are generated by the pressing force; the metal sheets having the concave portions and convex portions formed thereon are layered on each other; the burr at the apex of each convex portion of a lower-layer metal sheet is interlocked with the burr at the apex of each concave portion of an upper-layer metal sheet adjacent to the lower-layer metal sheet to integrate the metal sheets with each other; and an active substance is charged into spaces between the upper-layer metal sheet and the lower-layer metal sheet through an aperture at the apex of each of the concave portions and convex portions. <IMAGE>
Patent EP-1005365-A4 (EP)
Title: Abundant extracellular products and methods for their production and use
Inventor: HORWITZ MARCUS A
IPC: A61P31/04
Filed: 1998-01-15
Abstract: Vaccines based on one or more combinations of majorly abundant extracellular products of pathogens and methods for their use and production are presented. The most prevalent or majorly abundant extracellular products of a target pathogen are selected irrespective of their absolute molecular immunogenicity and used as vaccines to stimulate a protective immune response in mammalian hosts against subsequent infection by the target pathogen. The majorly abundant extracellular products may be characterized and distinguished by their respective N-terminal amino acid, amino acid, or DNA sequences. As the vaccines may comprise different combinations of the extracellular products, subunits thereof, or encoding nucleic acids, a broad range of effective immunotherapeutic compositions are provided by the present invention. In addition to other infectious agents, the vaccines so produced can be used to stimulate an effective immune response against intracellular pathogens and in particular Mycobacterium tuberculosis.
Patent EP-1067968-A4 (EP)
Inventor: BURGESON ROBERT E
IPC: A61K48/00
Filed: 1998-04-30
Abstract: L'invention concerne des procédés d'évaluation d'un traitement en fonction de son action cutanée. L'invention comprend aussi des animaux transgéniques, par exemple des souris présentant un gène marqueur couplé à un promoteur de dermo-métabolisme.
Patent EP-0986923-A4 (EP)
Title: System and method for a network-based call continuation service
Inventor: BECKER STEVEN C
IPC: H04W4/16
Filed: 1998-06-05
Abstract: The present invention is a system and method for continuing a telephone call placed by a caller (102) to a call center (120) in a telecommunications network (100). When a caller attempts to make a call to the call center that is unavailable, the system obtains callback information for the caller including a telephone number where the caller can be reached. The call is then ended. When the call center is again available, the system continues the call by placing a call to the caller at said telephone number, placing a call to the destination, and joining the two calls.
Patent EP-0993039-A4 (EP)
Inventor: URASAKI NAOYUKI
IPC: H05K3/28
Filed: 1998-06-26
Abstract: Substrat (8) destiné au montage de plaquettes à semi-conducteur, sur lequel on fixe avec un adhésif une plaquette à semi-conducteur (3) présentant des protubérances (4). On applique sur le substrat (8), au niveau de la zone de montage de la plaquette, une couche isolante (6) présentant une ouverture, ce qui empêche l'exposition des conducteurs de câblage (2) sur la surface du substrat (8) à la limite de ladite zone de montage. Ce procédé permet d'obtenir un substrat présentant une fiabilité améliorée en ce qui concerne la solidité de la liaison et pouvant être produit en série.
Patent EP-1019057-A4 (EP)
Title: A method of preventing or treating estrogen-dependent diseases and disorders
Inventor: MCDONNELL DONALD P
IPC: A61P3/10
Filed: 1998-08-14
Abstract: The present invention relates, in general, to the treatment of estrogen-dependent diseases and disorders and, in particular, to a method of treating estrogen-dependent cancers, particularly breast cancer, with antiestrogens.
Patent EP-1042882-A4 (EP)
Inventor: MALISZEWSKI RICHARD L
IPC: H04L9/10
Filed: 1998-12-12
Abstract: Cette invention permet d'identifier un processus distant (12), actif dans un espace d'adresse différent de celui d'un processus local (10), cette opération d'authentification consistant à créer, par le processus local, un module inviolable (14) contenant un secret temporaire (16);;; envoyer ce module inviolable et une intervation (18) du processus local au processus distant, à exécuter le module inviolable par le processus distant et à reprendre le secret, lorsque l'intégrité du processus distant est vérifiée par le module inviolable, à coder l'intervention en utilisant le secret pour produire une réaction (20); à envoyer cette réaction au processus local et à décoder la réaction par le processus local. Le module inviolable comprend éventuellement une demande d'information en provenance du second processus et la réaction contient la réponse à cette demande d'information.
Patent EP-0990847-A4 (EP)
Inventor: KITTA TAKEHIRO
IPC: F27D3/08
Filed: 1999-03-25
Abstract: L'invention concerne un four de fusion de cendres, capable de fonctionner de manière à la fois fiable et efficace et de loger des charges variables, ce four étant destiné à être utilisé pour un processus de fusion mélangée permettant de chauffer et de fondre des cendres principales et des cendres volantes simultanément, afin d'obtenir des cendres brûlées. Dans ce four, les cendres principales (ou cendres à gros grain) situées sur une couche supérieure, et les cendres volantes (ou cendres à grain fin) situées sur une couche inférieure sont fournies en couches à l'aide d'un brûleur, tout en étant déplacées vers l'autre extrémité, ce qui permet au brûleur, si celui-ci se présente sous la forme d'un brûleur enrichi en oxygène, de réguler correctement la quantité d'oxygène ajoutée à l'air (compte tenu de la variation de la concentration). Une fois les cendres chauffées et fondues sous l'effet de la combustion de ce brûleur enrichi en oxygène, on peut réguler correctement, outre la quantité de carburant, la quantité de cendres nécessaire suite à une variation de la concentration d'oxygène.
Patent EP-1068357-A4 (EP)
Title: Therapeutic and diagnostic applications based on the role of the cxcr-4 gene in tumorigenesis
Inventor: MURPHY GERALD P
IPC: A61K39/395
Filed: 1999-03-29
Abstract: The present invention relates to the identification of a novel role of CXCR-4 in cell transformation and aberrant cellular proliferation. In particular, the present invention relates to the altered gene expression of CXCR-4 in a number of primary tumors and cell lines derived from tumors, in addition to, the altered gene expression of ligands for CXCR-4. Further, the present invention relates, in part, to the Applicants' surprising discovery that the inhibition of CXC R- 4 gene expression or the inhibition of CXCR-4 activity in transformed cells reverses the transformed phenotype.
Patent EP-1128755-A4 (EP)
Title: Container with straw and method of manufacture
Inventor: LIPSON ERIK
IPC: A47G21/18
Filed: 1999-11-04
Abstract: A combination drinking container and straw and method of manufacture. The container has at least one straw retaining member molded into either the outer or inner surface of the container wall, or a portion of the wall may be shaped to include a constricted stem. A malleable straw is fitted onto each such retaining member so that at least a portion of the pathway of the straw is defined by the retaining members. A first end of the straw extends into the container and a second end extends upwardly so that beverage may be sipped therefrom. A lid may close the container, the lid optionally including an aperture to permit passage of the straw, the straw passing through the aperture. Also disclosed is a lidded container wherein the lid is provided with an aperture. A first portion of a drinking straw extends from inside the container, through the hole and to the container's outside to form a hinge for the lid. A second portion of the straw is attached to the container. In this way, the lid remains attached to the straw and container even when removed from the container.
Patent AT-525080-A4 (AT)
Title: Möbel mit einem auf einem Grundgestell aufliegenden Polster
IPC: A47C17/18
Filed: 2021-09-22
Abstract: Es wird ein Möbel (1) mit einem auf einem Grundgestell (2) aufliegenden Polster (6), wobei das Grundgestell einen Hauptteil (3) und zwei um zueinander quer verlaufende Schwenkachsen (5a,5b,5c) schwenkbar am Hauptteil (3) angelenkte Seitenteile (4a,4b,4c) umfasst, beschrieben. Um unabhängig von der Beschaffenheit des Polsters eine bezüglich des Verkippungswinkels der Seitenteile große Bewegungsfreiheit zu ermöglichen und dennoch eine einfache Auswechselbarkeit des Polsters zu erlauben, wird vorgeschlagen, dass der Polster (6) an beiden plattenförmig ausgebildeten Seitenteilen (4a,4b,4c) quer zur Schwenkachse (5a,5b,5c) des jeweiligen Seitenteils (4a,4b,4c) verschiebbar gelagert ist.